BOLD vs CFLT · P/E 0.1, $24.6M cap vs rev $963.6M
Boundless Bio, Inc. Common Stock (BOLD) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the BOLD and CFLT stock pages for the full models.
Not investment advice.